Shinbaro clinical trials
How each study uses shinbaro is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Green Cross Corporation (2) · Seoul National University Hospital (1)
Studies
Open first, then newest update. How each study uses shinbaro is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy of Shinabro in Hand OsteoarthritisCompletedPhase 2/3Seoul National University HospitalNCT01910116Written as ShinbaroHow we know
- To Evaluate the Safety of 'Shinbaro Capsule'in Patients With OsteoarthritisCompletedPhase 4Green Cross CorporationNCT01604239Written as Shinbaro CapsuleHow we know
- Efficacy and Safety of Shinbaro CapsuleCompletedPhase 3Green Cross CorporationNCT01535417Written as Shinbaro CapsuleHow we know